Next Article in Journal
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Next Article in Special Issue
Transcriptome Analysis of Human Endogenous Retroviruses at Locus-Specific Resolution in Non-Small Cell Lung Cancer
Previous Article in Journal
Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates
Previous Article in Special Issue
NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 13
Issue 19
10.3390/cancers13194825
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2021, 13(12), 2980.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980

by
José Miguel Pardo-Sánchez
1,
Nuria Mancheño
2,†,
José Cerón
3,†,
Carlos Jordá
3,†,
Emilio Ansotegui
4,
Óscar Juan
5,
Sarai Palanca
6,
Antonio Cremades
7,
Carolina Gandía
1 and
Rosa Farràs
1,*
1
Oncogenic Signalling Laboratory, Centro de Investigación Príncipe Felipe, 46012 Valencia, Spain
2
Department of Pathology, University and Polytechnic La Fe Hospital, 46026 Valencia, Spain
3
Department of Thoracic Surgery, University and Polytechnic La Fe Hospital, 46026 Valencia, Spain
4
Department of Pulmonology, University and Polytechnic La Fe Hospital, 46026 Valencia, Spain
5
Department of Medical Oncology, University and Polytechnic La Fe Hospital, 46026 Valencia, Spain
6
Molecular Biology Unit, Service of Clinical Analysis, University and Polytechnic La Fe Hospital, 46026 Valencia, Spain
7
Department of Pathology, Hospital Universitario de la Ribera, 46600 Alzira, Spain
*
Author to whom correspondence should be addressed.
†
These authors equally contributed to this manuscript.
Cancers 2021, 13(19), 4825; https://doi.org/10.3390/cancers13194825
Submission received: 8 September 2021 / Accepted: 14 September 2021 / Published: 27 September 2021
(This article belongs to the Special Issue Non-small Cell Lung Cancer--Tumor Biology)
Versions Notes
The authors would like to make a correction to their published paper [1].
There was a mistake in the original version of the article.
1.
Figure S1A was uploaded instead of Figure 2A. Thus, Figure 2 should be replaced with the following version:
Cancers 13 04825 i001
2.
In Table 3, the % allele frequencies of samples #17 and 26# were missing. The original Table 3 should be replaced with the following Table 3:
3.
In the Funding Section, acknowledgment to co-funding by ERDF/ESF, “Investing in your future” was missing. The Funding Section should be replaced with the following statement:
  • Funding: This research was funded by the Fondo de Investigación Sanitaria, ISCIII, grant numbers PI15-209 and PI20-194, co-funded by ERDF/ESF, “Investing in your future”. J.M.P.-S. was funded by the Ministerio de Educación, Cultura, y Deporte, grant number FPU13/02755.
4.
In addition, some minor typos have been corrected.
In the paragraph after Figure 2, “p.N11S” should be replaced with “p.N26S”.
In the paragraph before the subheading of Section 2.5, “increased” should be replaced with “increase”.
In the second paragraph of the Discussion Section, “SLCL” should be replaced with “SCLC”.
In the penultimate paragraph of the Discussion Section, “NSLCL” should be replaced with “NSCLC”.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Pardo-Sánchez, J.M.; Mancheño, N.; Cerón, J.; Jordá, C.; Ansotegui, E.; Juan, Ó.; Palanca, S.; Cremades, A.; Gandía, C.; Farràs, R. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980. [Google Scholar] [CrossRef]
Table
Table 3. Somatic mutation in surgically resected tumors that generated PDXs.
Table 3. Somatic mutation in surgically resected tumors that generated PDXs.
Sample NumberPatient
Code		Genetic Alterations
(Oncomine™ Focus Assay)
#1LF01ERBB4 c.2139G>T; p.L713F9% allele frequency
#4LF05KRAS c.34G>T; p.G12C67% allele frequency
#8LF09KRAS c.34G>T; p.G12C7% allele frequency
#12LF15KRAS c.34G>T; p.G12C
ERBB2 c.2524G>A; p.V842I		32% allele frequency
4% allele frequency
#17LF20ERBB2 c.2301C>G; p.I767M
MYC c.77A>G; p.N26S		74% allele frequency
58% allele frequency
#26LF29MET c.3029 C>T; p.T1010I29% allele frequency
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pardo-Sánchez, J.M.; Mancheño, N.; Cerón, J.; Jordá, C.; Ansotegui, E.; Juan, Ó.; Palanca, S.; Cremades, A.; Gandía, C.; Farràs, R. Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980. Cancers 2021, 13, 4825. https://doi.org/10.3390/cancers13194825

AMA Style

Pardo-Sánchez JM, Mancheño N, Cerón J, Jordá C, Ansotegui E, Juan Ó, Palanca S, Cremades A, Gandía C, Farràs R. Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980. Cancers. 2021; 13(19):4825. https://doi.org/10.3390/cancers13194825

Chicago/Turabian Style

Pardo-Sánchez, José Miguel, Nuria Mancheño, José Cerón, Carlos Jordá, Emilio Ansotegui, Óscar Juan, Sarai Palanca, Antonio Cremades, Carolina Gandía, and Rosa Farràs. 2021. "Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980" Cancers 13, no. 19: 4825. https://doi.org/10.3390/cancers13194825

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop